You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low intermediate-grade lung neuroendocrine tumors (Typical and Atypical carcinoids)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Neuroendocrine Tumors Trial in New Orleans (ABI-009)

Terminated
Has Results
  • Neuroendocrine Tumors
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
May 17, 2021

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting
  • NSCLC
  • +6 more
  • Oral MRT-2359
  • Scottsdale, Arizona
  • +7 more
Dec 20, 2022

Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor

Completed
Has Results
  • Advanced Digestive System Neuroendocrine Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 8, 2020

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

Terminated
Has Results
  • Neuroendocrine Tumors
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Neuroendocrine Tumors Trial (64Cu-SARTATE)

Completed
  • Neuroendocrine Tumors
  • (no location specified)
Jun 18, 2020

Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET Trial in Worldwide (Surufatinib)

Recruiting
  • Neuroendocrine Tumours
  • +2 more
  • Atlanta, Georgia
  • +18 more
Mar 10, 2022

Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

Recruiting
  • Atypical Carcinoid Tumor
  • +18 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +425 more
Aug 12, 2022

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

Completed
Has Results
  • Gastrin-Producing Neuroendocrine Tumor
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 25, 2020

Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

Recruiting
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma in Situ
  • Vacuum-assisted excisional biopsy
  • Milan, Italy
    Breast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

    Recruiting
    • HRD Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Large-Cell Neuroendocrine Carcinoma Trial in Lexington (Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma,

    Recruiting
    • Large-Cell Neuroendocrine Carcinoma
    • Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma
    • Treatment for Small Cell Lung Cancer
    • Lexington, Kentucky
      Markey Cancer Center, University of Kentucky
    Jan 12, 2022

    GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

    Enrolling by invitation
    • GEP-NET
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 24, 2023

    Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

    Recruiting
    • Acinar Cell Carcinoma
    • +93 more
    • Biospecimen Collection
    • +2 more
    • Birmingham, Alabama
    • +998 more
    Aug 23, 2022

    Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Oxaliplatin-based chemotherapy
    • Alkylating-based chemotherapy
    • Amiens, France
    • +18 more
    Mar 15, 2022

    Clinical, Radiological, Histologic and Molecular Features

    Recruiting
    • Meningeal Melanocytoma
    • +3 more
      • Nancy, France
        Nancy University Hospital Center
      Jul 31, 2023

      HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

      Not yet recruiting
      • HPV Infection
      • HPV-Related Cervical Carcinoma
      • FluBHPVE6E7
      • Placebo
      • (no location specified)
      Apr 24, 2023

      Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

      Not yet recruiting
      • Neuroendocrine Tumors
      • +4 more
      • Newport Beach, California
      • +2 more
      Aug 16, 2023

      Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

      Not yet recruiting
      • Neuroendocrine Tumors
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Feb 17, 2023

      Symptoms of Frey's Syndrome

      Recruiting
      • Parotid Neoplasms
      • Questions
      • Roma, Italy
        Maria Raffaella Marchese
      Feb 11, 2023